Evidence map›Paper›PMID 38912959›Full record

ArticleThe Journal of infectious diseases2024

Hepatitis B Surface Antigen Loss: What Does Integration Have to Do With a Functional Hepatitis B Virus Cure?

Ashwin Balagopal, Chloe L Thio

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ashwin BalagopalDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-6143-3104
Chloe L ThioDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-8851-8319

Funding

Spatial Models of Intrahepatic Hepatitis C Virus Propagation in HumansR01AI116868 · NIAID · TRIAD NATIONAL SECURITY, LLC · PI ASHWIN BALAGOPAL, Ruy M Ribeiro · 2016 to 2026
$8.5M
Characterization of silently HBV-infected hepatocytes in HIV co-infectionR01AI138810 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BALAGOPAL, ASHWIN, THIO, CHLOE L · 2018 to 2021
$3.2M
HBV cccDNA transcriptional silencing with and without HIVR01AI181659 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ASHWIN BALAGOPAL, CHLOE L THIO · 2024 to 2026
$2.4M
Mechanisms of HBV cccDNA transcriptional regulation in persons with and without HIVR56AI138810 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BALAGOPAL, ASHWIN, THIO, CHLOE L · 2023 to 2023
$811k
Unraveling sources of hepatitis B surface antigen before and after nucleos(t)ide analogue treatment in People with HIVR21AI157760 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BALAGOPAL, ASHWIN, THIO, CHLOE L · 2021 to 2022
$450k
Identifying the source of hepatitis B surface antigen in people with hepatitis B-HIV co-infectionR21AI165166 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BALAGOPAL, ASHWIN, THIO, CHLOE L · 2021 to 2022
$450k
NIAID NIH HHS R01 AI116868NIAID NIH HHS R01 AI138810NIAID NIH HHS R01 AI181659NIAID NIH HHS R21 AI157760NIAID NIH HHS R21 AI165166NIAID NIH HHS R56 AI138810
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis B Surface AntigensHepatitis B virusAntiviral AgentsHepatitis BHepatitis B, ChronicHumansVirus IntegrationAntiviral AgentsHepatitis B Surface Antigens

Identifiers

PMID38912959
PMCPMC12102462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.